PROJ-SUN_1170x120_6-24-20

Takeda Pharmaceuticals U.S.A.

Takeda, Lundbeck make vortioxetine available in U.S.

Takeda, Lundbeck make vortioxetine available in U.S.

DEERFIELD, Ill. — Trintellix (vortioxetine), a once-daily oral antidepressant indicated for the treatment of major depressive disorder (MDD) in adults, has been rolled out to U.S. pharmacies by Takeda Pharmaceuticals U.S.A. and Lundbeck. The companies recently announced that the trade name for their vortioxetine product in this country would be changed to Trintellix to avoid

Takeda U.S.A. names president

DEERFIELD, Ill. — Ramona Sequeira has been appointed president of Takeda Pharmaceuticals U.S.A. Inc., a unit of Takeda Pharmaceutical Co. The company said this week that Sequeira will lead all business operations for the United States and report to Christophe Weber, president and chief executive officer of Takeda. She joins Takeda from her most recent